Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
09/2008
09/17/2008EP1970370A1 Amorphous form of 1,2-dihydropyridine compound
09/17/2008EP1968945A2 Muscarinic receptor antagonists
09/17/2008EP1968705A1 Pharmaceutical combination of a pde-5 inhibitor and a 5-alpha reductase inhibitor
09/17/2008EP1968561A2 Treatment of renal disorders, diabetic nephropathy and dyslipidemias
09/17/2008EP1463525B1 Compositions and methods for the diagnosis and treatment of tumor
09/17/2008EP1447400B1 Bicyclic compound
09/17/2008EP1379557B1 Use of cd25 binding molecules in steroid-resistant patients
09/17/2008EP1245676B1 Human monoclonal antibodies against tgf-beta ii receptor and medicinal use thereof
09/17/2008CN101264303A Chinese medicine for treating acute and chronic nephritis and preparation thereof
09/17/2008CN101264300A Medicaments assembly for moistening lung and nourishing kidney, enriching blood and tonifying Qi and preparation thereof
09/17/2008CN101264283A Chinese medicine for treating chronic prostatitis
09/17/2008CN101264220A Medicaments assembly for tonifying kidney and invigorating spleen, activating blood circulation and removing stasis and preparation thereof
09/17/2008CN101264210A Chinese herbal medicine for treating prostatitis
09/17/2008CN101264187A Medicinal composition for treating chronic prostatitis and prostatic hyperplasia
09/17/2008CN101264179A Compound proprietary Chinese medicine for treating chronic prostatitis
09/17/2008CN101264073A Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
09/17/2008CN101264072A Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
09/17/2008CN101263897A Original flavor edible burdock kidney-nourishing porridge
09/17/2008CN100418968C Pirazino(aza)indole derivatives
09/17/2008CN100418965C Imidazopyridine derivatives
09/17/2008CN100418955C Novel Benzo-fused heterocycles
09/17/2008CN100418951C Cycloamine derivative and its use as medicine
09/17/2008CN100418529C Application of Nepider in preparing medicine to accelerate ejection of calculus for urinary system
09/16/2008US7425637 mitogen-activated protein/extracellular signal-regulated (MAP/ERK)Kinase pathways; 6-(4-bromo-2-fluorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxyethoxy)-amide; hyperproliferative diseases; anticarcinogenic and antiinflammatory agent
09/16/2008US7425616 Use of C-reactive protein to treat immune complex-mediated renal disease
09/16/2008US7425567 Inhibitor of phosphodiesterase enzyme, 2-(4-(3-cyclopentyloxy-4-difluoromethoxyphenyl)-4-cyanopiperidin-1-yl)acetic acid monohydrate; treating inflammatory diseases, diabetics, allergic diseases, autoimmune diseases, ocular diseases, osteoporosis, Parkinson's disease, dementia; chemical intermediates
09/16/2008US7425566 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them
09/16/2008US7425563 Excellent poly (ADP-ribose) synthetase inhibitors; various ischemic diseases, inflammatory diseases, neurodegenerative diseases, diabetes, septic shock, cephalic injury; 1,2-Dihydro-4-[4-(dimethylaminomethyl)phenyl]-5-hydroxy-1-oxoisoquinoline
09/16/2008US7425560 Thioxanthine derivatives as myeloperoxidase inhibitors
09/16/2008US7425555 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors
09/16/2008US7425536 Feline hepatocyte growth factor
09/16/2008US7425532 Use of alanyl aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors
09/16/2008CA2370501C Pharmaceutical composition for the therapy of lower urinary tract symptoms
09/12/2008WO2008108445A1 Benzoxazepine derivatives and use thereof
09/12/2008WO2008108322A2 Composition and method for protecting mitochondria
09/12/2008WO2008107544A1 Derivatives of n-(heteroaryl)-1-heteroaryl-1h-indol-2-carboxamids, preparation thereof and therapeutic use thereof
09/12/2008WO2008107446A1 Use of lhrh antagonists for the treatment of lower urinary tract symptoms, in particular overactive bladder and/or detrusor overactivity
09/12/2008WO2008107418A1 Fused pyrimidinone compounds as mglur ligands
09/12/2008WO2008107399A1 Substituted oxindole compounds
09/12/2008WO2007137168A3 Bridged aryl piperazines derivatives useful for the treatment of cns, gi-urinary and reproductive disorders
09/12/2008CA2679690A1 Use of lhrh antagonists for the treatment of lower urinary tract symptoms, in particular overactive bladder and/or detrusor overactivity
09/12/2008CA2678463A1 Fused pyrimidinone compounds as mglur ligands
09/11/2008US20080221218 Ligand binding member comprisingoligoamines covalently linked to an organic template; movement of oligoamines is conformationally restricted; oligoamines are same or different and are independently straight chained, cyclic or branched; phosphate binding in water purification; renal dialysis
09/11/2008US20080221186 4-(substituted cycloalkylmethyl) Imidazole-2-Thiones, 4-(substituted cycloalkenylmethyl) Imidazole-2-Thiones, 4-(substituted cycloalkylmethyl) Imidazol-2-Ones and 4-(substituted cycloalkenylmethyl) Imidazole-2-Ones and related compounds
09/11/2008US20080221155 Novel quinuclidine derivatives and medicinal compositions containing the same
09/11/2008US20080221101 Calcium receptor modulating agents
09/11/2008US20080221082 of the alpha V beta 3 integrin receptor; , thromboembolic events, cardiovascular disorders, lung diseases, disorders of the CNS, the kidney, the gastrointestinal tract or inflammation
09/11/2008US20080221039 Kinin Antagonists For Treating Bladder Dysfunction
09/11/2008US20080219972 Prostatic Acid Phosphatase (Pap) Materials and Methods of Use Thereof in the Prophylactic and Therapeutic Treatment of Prostate Cancer
09/10/2008EP1967523A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application
09/10/2008EP1967519A1 3,4-dihydrobenzoxazine compound and inhibitor of vanilloid receptor type 1 (vr1) activity
09/10/2008EP1967209A1 Therapeutic agent for prostate cancer
09/10/2008EP1967206A2 Anti-IgE vaccines
09/10/2008EP1967205A2 Anti-IgE vaccines
09/10/2008EP1967202A1 Use of LHRH Antagonists for the Treatment of Lower Urinary Tract Symptoms, in particular Overactive Bladder and/or Detrusor Overactivity
09/10/2008EP1966179A2 Darifenacin hydrobromide composition substantially free of oxidized darifenacin and salts thereof and processes for the preparation thereof
09/10/2008EP1965863A2 Pharmaceutical combination for the treatment of luts comprising a pde5 inhibitor and a muscarinic antagonist
09/10/2008EP1965800A2 Incontinence treatment methods
09/10/2008EP1965794A2 Octahydropyrano[3,4-c]pyrrole tachykinin receptor antagonists
09/10/2008EP1965782A1 Use of aminoalcohol derivatives for the treatment of overactive bladder
09/10/2008EP1438053B1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same
09/10/2008EP1427708B1 Amino-phthalazinone derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
09/10/2008EP1368302B1 Novel amino dicarboxylic acid derivatives
09/10/2008EP1303284B1 Compositions and methods for the treatment of skin damage
09/10/2008CN101259256A Chinese medicine for treating infantile enuresis
09/10/2008CN101259249A Chinese medicine preparation for treating head wind
09/10/2008CN101259243A Prostatitis pill
09/10/2008CN101259238A Medicaments assembly for recuperating and nourishing liver and kidney, promoting qi and dispersing mass and preparation thereof
09/10/2008CN101259232A Chinese medicinal composition for treating nephrotic syndrome and preparation thereof
09/10/2008CN101259225A Chinese medicine assembly for treating chronic renal insufficiency and preparation thereof
09/10/2008CN101259208A Kidney-nourishing life-prolonging capsule
09/10/2008CN101259190A Chinese medicine assembly for warming kidney, compensating spleen, benefitting qi and nourishing blood and preparation thereof
09/10/2008CN101259188A Chinese medicine for treating chronic kidney disease and preparation thereof
09/10/2008CN101259122A Use of hydroxyoleic acid and similar compounds in the production of medicaments
09/10/2008CN101259121A Use of hydroxyoleic acid and similar compounds in the production of medicaments
09/10/2008CN100417404C Chinese medicine for treating chronic nephritis
09/10/2008CN100417383C Effervescent tablet containing cefixime and its preparing method
09/09/2008US7423185 Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof
09/09/2008US7423177 Carboxamide derivatives as therapeutic agents
09/09/2008US7423175 Vanilloid receptor (VR1) antagonists; side effects reduction, oral availability; To treat urinary incontinence, urge urinary incontinence, overactive bladder, pain, and/or inflammatory diseases such as asthma and COPD; N-[2-(2-Fluorophenoxy)ethyl]-N'-(7-hydroxy-5,6,7,8-tetrahydro-1-naphthalenyl)-urea
09/09/2008US7423055 e.g., 2-(2-methyl-5-amino)phenyl-4-(3-pyridyl)-thiazole; c-kit inhibitors; treating cell proliferative, metabolic, allergic, and degenerative disorders.
09/09/2008US7423049 e.g., 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine; mitogen-activated protein kinase inhibitor; antiinflammatory agent, autoimmune diseases
09/09/2008US7423047 Arylamine substituted bicyclic heteroaromatic compounds as p38 kinase inhibitors
09/09/2008US7423020 Therapy for behavior disorders; quantitative analysis; measuring binding
09/09/2008US7423009 Method for treatment of kidney diseases
09/09/2008US7422846 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator
09/09/2008CA2460865C Quinoline derivatives as neuropeptide y antagonists
09/09/2008CA2412047C Shortened synthesis of 3,3-diarylpropylamine derivatives
09/09/2008CA2346868C Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent
09/04/2008WO2008106536A1 Use of silodosin in a once daily administration for treating benign prostatic hyperplasia
09/04/2008WO2008106125A2 Deuterated derivatives of silodosin as alpha la-adrenoceptor antagonists
09/04/2008WO2008106102A2 Inhibitors of rtp801 and their use in disease treatment
09/04/2008WO2008105526A1 Macrocyclic compound
09/04/2008WO2008105441A1 Poly(amino acid) compound having inhibitory activity on absorption of phosphorus and phosphorus absorption inhibitor
09/04/2008WO2008105181A1 Pharmaceutical agent for prevention and/or treatment of lower urinary tract symptom
09/04/2008WO2008104474A1 Diaminopyrimidines
09/04/2008WO2008104279A1 Imidazo[1,2-a]azines and their use as pharmaceuticals
09/04/2008US20080214659 Stage-Specific Reduction of LUTS in Prostate Disease
09/04/2008US20080214654 Substituted Benzyloxy-Phenylmethylamide Derivatives
09/04/2008US20080214653 Methods and Compositions for the Prevention and Treatment of Kindney Disease